| 2026-03-31 16:15:00 |
Nanobiotix Provides Business Update And Reports Full Year 2025 Financial Results
Global development program for jnj-1900 (nbtxr3) proceeded as planned, building toward opportunity to address one of the largest untapped markets in oncology through lead programs in head and neck cancer and lung cancer clinical results reported across multiple tumor types including esophageal cancer, pancreatic cancer, melanoma, head and neck cancer, and lung cancer that supported the broad potential of jnj-1900 (nbtxr3) across solid tumors treated with radiotherapy next to the completion of the transfer of sponsorship for nanoray-312 strengthened financial position through the closing of a non-dilutive royalty financing with healthcare royalty for up to $71 million and an amendment to the global licensing agreement for jnj-1900 (nbtxr3) advanced the curadigm nanoprimer platform with four new patent applications filed, new in vivo data presentations, external collaboration momentum building, and the launch of chemistry, manufacturing, and controls (cmc) activities to support both internal pipeline and external collaborations cash runway extended into early 2028 with €52.8 million in cash and cash equivalents as of december 31, 2025 clinical data readouts expected in 2026 from phase 1 and 2 studies in nsclc (re-irradiation), pancreatic cancer, melanoma and esophageal cancer conference call and webcast scheduled for april 1, 2026, at 8:00 a.m. edt / 2:00 p.m. |
| 2026-03-28 10:00:00 |
Icotyde™ (icotrokinra) One-year Results Confirm Lasting Skin Clearance And Favorable Safety Profile In Once‑daily Pill For Plaque Psoriasis
Johnson & johnson presents new data showing high rates of complete skin clearance achieved at week 24 and week 52 in iconic-advance 1 and 2 studies nearly 60% of adolescents treated with icotyde achieved completely clear skin at week 52 in the iconic-lead study spring house, pa., march 28, 2026 /prnewswire/ -- johnson & johnson (nyse: jnj) today announced new long-term 52-week data from the phase 3 iconic-advance 1 and 2 and iconic-lead studies, which assessed the efficacy and safety of icotyde™ (icotrokinra) in the treatment of patients with moderate-to-severe plaque psoriasis (pso). |
| 2026-03-27 06:31:00 |
Johnson & Johnson’s Darzalex® (daratumumab) Becomes The First Oncology Injectable Approved For Administration By Patients Or Caregivers
Landmark decision by chmp grants approval for self or caregiver administration for patients living with multiple myeloma1 milestone is a testament to ten years of daratumumab experience and innovation, continuing to transform multiple myeloma care beerse, belgium, march 27, 2026 (globe newswire) -- johnson & johnson today announced that the committee for medicinal products for human use (chmp) of the european medicines agency (ema) has granted approval for a type ii variation to the labelling for darzalex® (daratumumab) subcutaneous (sc) formulation. the label update enables patients living with multiple myeloma or their caregivers to administer daratumumab from the fifth dose, if determined to be appropriate by their healthcare professional and following proper training.1 this landmark decision makes daratumumab the first oncology injectable approved for self-administration in europe.1 offering greater flexibility in care with this label update, patients and their healthcare professionals can work together to decide the most suitable choice of administration.1 it applies to all ten therapeutic indications of daratumumab sc for multiple myeloma, smouldering multiple myeloma and light chain (al) amyloidosis. |
| 2026-03-23 07:45:00 |
Craig Tendler, M.d., Jnj’s Former Global Head Of Oncology Clinical Development, To Lead Tuhura Bioscience’s Vista Program In Aml And Other Blood Related Cancers
Distinguished physician with a career spanning over 29 years in drug development and medical affairs highlighted by blockbuster successes in hematology and oncology coordinated and achieved more than 30 oncology regulatory approvals and 15 new medical entity approvals, including four biologic or cell therapy approvals for various stages of multiple myeloma currently generating more than $16 billion in worldwide sales tampa, fla., march 23, 2026 /prnewswire/ -- tuhura biosciences, inc. (nasdaq:hura) (’tuhura’ or the ’company’), a phase 3 immuno-oncology company developing novel therapeutics to overcome resistance to cancer immunotherapy, today announced dr. craig l. |
| 2026-03-18 07:49:00 |
Fda Approval Of Icotyde™ (icotrokinra) Ushers In New Era For First-line Systemic Treatment Of Plaque Psoriasis With A Targeted Oral Peptide
Johnson & johnson introduces the first and only il-23r targeted oral peptide that delivers complete skin clearance and favorable safety profile in a once-daily pill icotyde offers an innovative new option for patients with moderate-to-severe plaque psoriasis to address patients cycling on topical therapies in need of systemic treatment spring house, pa., march 18, 2026 /prnewswire/ -- johnson & johnson (nyse: jnj) announced today that the u.s. food and drug administration (fda) has approved icotyde™ (icotrokinra), an interleukin-23 (il-23) receptor antagonist for the treatment of moderate-to-severe plaque psoriasis in adults and pediatric patients 12 years of age and older who weigh at least 40 kg who are candidates for systemic therapy or phototherapy.1 icotyde is the first and only targeted oral peptide that precisely blocks the il-23 receptor.2 ’icotyde delivers something unique in psoriasis treatment – combining skin clearance with a favorable safety profile in a once–daily pill, making it an easy addition to a patient’s routine,’ said linda stein gold, m.d. |
| 2026-03-16 11:00:00 |
Sm9obnNvbi AmIEpvaG5z b24gRHJpdm VzIElubm92 YXRpb24gSW 4gUHVsc2Vk IEZpZWxkIE FibGF0aW9u IFdpdGggUG VydSBMYXVu Y2g=
TGltYSwgcG VydS0tKGJ1 c2luZXNzIH dpcmUpLS1q b2huc29uIC Ygam9obnNv biBhbm5vdW 5jZWQgdGhl IGFycml2YW wgaW4gcGVy dSBvZiBhIG 5ldyBwdWxz ZWQgZmllbG QgYWJsYXRp b24gKHBmYS kgdGVjaG5v bG9neSBmb3 IgdGhlIHRy ZWF0bWVudC BvZiBkcnVn LXJlZnJhY3 RvcnkgcGFy b3h5c21hbC BhdHJpYWwg ZmlicmlsbG F0aW9uLiB0 aGlzIGluY2 9ycG9yYXRp b24gcmVwcm VzZW50cyBh IHNpZ25pZm ljYW50IGFk dmFuY2UgaW 4gdGhlIGFw cHJvYWNoIH RvIGNhcmRp YWMgYXJyaH l0aG1pYXMs IHdpdGggYm VuZWZpdHMg aW4gdGVybX Mgb2Ygc2Fm ZXR5LCBwcm VjaXNpb24s IGFuZCBwcm 9jZWR1cmFs IGVmZmljaW VuY3kuMSDi gJl3aXRoIH RoaXMgbGF1 bmNoLCBwZX J1IGpvaW5z IHRoZSBsYX RpbiBhbWVy aWNhbiBjb3 VudHJpZXMg dGhhdCBhbH JlYWR5IGhh dmUgdGhpcy B3b3JsZC1j bGFzcyBpbm 5vdmF0aW9u LCB1c2VkIG luIGludGVy bmF0aW9uYW wgcmVmZXJl bmMu
|
| 2026-03-13 13:15:00 |
RXZlLW9mLX RyaWFsICQ2 NW0gU2V0dG xlbWVudCBQ cmVsaW1pbm FyaWx5IEFw cHJvdmVkIE luIE5vdmVs IEFudGl0cn VzdCBDbGFz cyBBY3Rpb2 4gQWdhaW5z dCBKJmogU3 Vic2lkaWFy eSBBY3RlbG lvbiBQaGFy bWFjZXV0aW NhbHM=
UGxhaW50aW ZmcyBhbGxl Z2VkIHRoZS BhbnRpY29t cGV0aXRpdm Ugc2NoZW1l IGZvcmNlZC B0cmFjbGVl ciBwdXJjaG FzZXJzIHRv IHBheSBoaW doZXIgcHJp Y2VzIGFuZC BkZWxheWVk IG1hcmtldC BlbnRyeSBv ZiBsZXNzLW Nvc3RseSBn ZW5lcmljIH ZlcnNpb25z Lg==
|
| 2026-03-13 12:35:00 |
Sm9obnNvbi AmIEpvaG5z b24gSGlnaG xpZ2h0cyBQ cm9taXNpbm cgRmlyc3Qt aW4taHVtYW 4gRXJkYS1p ZHJzIChmb3 JtZXJseSBU YXItMjEwKS BSZXN1bHRz IEluIEludG VybWVkaWF0 ZS1yaXNrIE 5vbi1tdXNj bGUtaW52YX NpdmUgQmxh ZGRlciBDYW 5jZXI=
RGF0YSBwcm VzZW50ZWQg YXQgZWF1ID IwMjYgc2hv dyBhbiA4OS BwZXJjZW50 IGNvbXBsZX RlIHJlc3Bv bnNlIHJhdG UgaW4gaW50 ZXJtZWRpYX RlLXJpc2sg ZGlzZWFzZS B3aXRoIGR1 cmFibGUgcm VzcG9uc2Vz IG9ic2Vydm VkIG92ZXIg MTggbW9udG hzIGFuZCB0 b2xlcmFibG Ugc2FmZXR5 IHByb2ZpbG XCoCBlcmRh LWlkcnMgaG FzIHRoZSBw b3RlbnRpYW wgdG8gYmUg dGhlIGZpcn N0IHRhcmdl dGVkIHRyZW F0bWVudCBm b3IgZWFybH nigJNzdGFn ZSBibGFkZG VyIGNhbmNl ciByYXJpdG FuLCBuLmou LCBtYXJjaC AxMywgMjAy NiAvcHJuZX dzd2lyZS8g LS3CoGpvaG 5zb24gJiBq b2huc29uIC hueXNlOmpu aikgdG9kYX kgYW5ub3Vu Y2VkIHJlc3 VsdHMgZnJv bSBhbiBvcG VuLWxhYmVs LCBtdWx0aW NlbnRlciBw aGFzZSAxIH N0dWR5IGV2 YWx1YXRpbm cgYW4gaW52 ZXN0aWdhdG lvbmFsIGlu dHJhdmVzaW NhbCBkcnVn LXJlbGVhc2 luZyBzeXN0 ZW0gd2l0aC BlcmRhZml0 aW5pYiAoZX JkYS1pZHJz KSBpbiBwYX RpZW50cyB3 aXRoIGludG VybWVkaWF0 ZS1yaXNrIG FuZCBoaWdo LXJpc2sgbm 9u4oCTbXVz Y2xlLWludm FzaXZlIGJs YWRkZXIgY2 FuY2VyIChu bWliYykgd2 hvc2UgdHVt b3JzIGhhcm JvciBzZWxl Y3QgZmlicm 9ibGFzdCBn cm93dGggZm FjdG9yIHJl Y2VwdG9yIC hmZ2ZyKSBh bHRlcmF0aW 9ucy4=
|
| 2026-03-12 08:00:00 |
Sm9obnNvbi AmIEpvaG5z b24gQW5ub3 VuY2VzIEZk YSBBcHByb3 ZhbCBPZiBU ZWNuaXMgUH VyZXNlZSBJ bnRyYW9jdW xhciBMZW5z LCBBIEJyZW FrdGhyb3Vn aCBTb2x1dG lvbiBGb3Ig VS5zLiBDYX RhcmFjdCBQ YXRpZW50cw ==
SmFja3Nvbn ZpbGxlLCBm bGEuLS0oYn VzaW5lc3Mg d2lyZSktLW pvaG5zb24g JiBqb2huc2 9uIGFubm91 bmNlcyBmZG EgYXBwcm92 YWwgb2YgdG VjbmlzIHB1 cmVzZWUgaW 50cmFvY3Vs YXIgbGVucy wgYSBicmVh a3Rocm91Z2 ggc29sdXRp b24gZm9yIH Uucy4gY2F0 YXJhY3QgcG F0aWVudHMu
|
| 2026-03-05 15:55:00 |
Sm9obnNvbi AmIEpvaG5z b24gQW5ub3 VuY2VzIFUu cy4gRmRhIE FwcHJvdmFs IE9mIFRlY3 ZheWxpwq4g UGx1cyBEYX J6YWxleCBG YXNwcm/Cri BGb3IgUmVs YXBzZWQvcm VmcmFjdG9y eSBNdWx0aX BsZSBNeWVs b21hLCBPZm ZlcmluZyBB IFBvdGVudG lhbCBOZXcg U3RhbmRhcm QgT2YgQ2Fy ZSBBcyBFYX JseSBBcyBT ZWNvbmQgTG luZQ==
QXBwcm92YW wgYmFzZWQg b24gdW5wcm VjZWRlbnRl ZCBwaGFzZS AzIGRhdGEg ZGVtb25zdH JhdGluZyBz dGF0aXN0aW NhbGx5IHNp Z25pZmljYW 50IGltcHJv dmVtZW50cy BpbiBwcm9n cmVzc2lvbi DigJMgZnJl ZSBzdXJ2aX ZhbCBhbmQg b3ZlcmFsbC BzdXJ2aXZh bCB2ZXJzdX Mgc3RhbmRh cmQgb2YgY2 FyZSByZWdp bWVucyA4My 4zJSBvZiBw YXRpZW50cy B3ZXJlIGFs aXZlIGF0IH RocmVlIHll YXJzLCBpbm RpY2F0aW5n IGR1cmFibG UgY2xpbmlj YWwgYmVuZW ZpdCBob3Jz aGFtLCBwYS 4sIG1hcmNo IDUsIDIwMj YgL3BybmV3 c3dpcmUvIC 0twqBqb2hu c29uICYgam 9obnNvbiAo bnlzZTpqbm opLCBhIHdv cmxkd2lkZS BsZWFkZXIg aW4gbXVsdG lwbGUgbXll bG9tYSB0aG VyYXBpZXMs IHRvZGF5IG Fubm91bmNl ZCB0aGF0IH RoZSB1LnMu IGZvb2QgYW 5kIGRydWcg YWRtaW5pc3 RyYXRpb24g KGZkYSkgYX Bwcm92ZWQg dGVjdmF5bG nCriAodGVj bGlzdGFtYW ItY3F5dikg cGx1cyBkYX J6YWxleCBm YXNwcm8gwq 4gKGRhcmF0 dW11bWFiIG FuZCBoeWFs dXJvbmlkYX NlLWZpaGop IGZvciB0aG UgdHJlYXRt ZW50IG9mIG FkdWx0cyB3 aXRoIHJlbG Fwc2VkIG9y IHJlZnJhY3 RvcnkgbXVs dGlwbGUgbX llbG9tYSAo cnJtbSkgd2 hvIGhhdmUg cmVjZWl2ZW QgYXQgbGVh c3Qgb25lIH ByaW9yIGxp bmUgb2YgdG hlcmFweSwg aW5jbHVkaW 5nIGEgcHJv dGVhc29tZS BpbmhpYml0 b3IgYW5kIG FuIGltbXVu b21vZHVsYX RvcnkgYWdl bnQuMSB0ZW N2YXlsacKu IGFuZCBkYX J6YWxleCBm YXNwcm8gwq 4gd29yayBz eW5lcmdpc3 RpY2FsbHkg dG8gcHJpbW UgYW5kIGFj dGl2YXRlIH RoZSBpbW11 bmUgc3lzdG VtIHRvIGVy YWRpY2F0ZS BteWVsb21h IGNlbGxzIH RoYXQgZXhw cmVzcyB0aG UgYmNtYSBw cm90ZWluLj EgdGhpcyBh cHByb3ZhbC BvZmZlcnMg YSBwb3Rlbn RpYWwgbmV3 IHN0YW5kYX JkIG9mIGNh cmUgKHNvYy kgYXMgZWFy bHkgYXMgc2 Vjb25kIGxp bmUgYW5kIG JyaW5ncyBh IG5vdmVsIH RyZWF0bWVu dCBhcHByb2 FjaCBmb3Ig dGhlIDQwJS BvZiBwYXRp ZW50cyB3aX RoIG11bHRp cGxlIG15ZW xvbWEgd2hv IGV4cGVyaW VuY2UgZGlz ZWFzZSByZW xhcHNlLjIg wqAgbXVsdG ltZWRpYSBh c3NldHMgZm 9yIG1lZGlh IGFyZSBhdm FpbGFibGXC oCBoZXJlLg ==
|
| 2026-03-03 08:03:00 |
Sm9obnNvbi AmIEpvaG5z b24gVGhlcm FweSBOaXBv Y2FsaW1hYi BHcmFudGVk IFUucy4gRm RhIEZhc3Qg VHJhY2sgRG VzaWduYXRp b24gSW4gU3 lzdGVtaWMg THVwdXMgRX J5dGhlbWF0 b3N1cyAoc2 xlKQ==
RmFzdCB0cm FjayBkZXNp Z25hdGlvbi ByZWZsZWN0 cyB0aGUgdW 5tZXQgbmVl ZCBpbiB0aG lzIHNlcmlv dXMgZGlzZW FzZSBhbmQg ZW5hYmxlcy B0aGUgcG90 ZW50aWFsIG ZvciBhbiBh Y2NlbGVyYX RlZCBmZGEg cmV2aWV3IH RpbWVsaW5l IHRoZSBkZX NpZ25hdGlv biBpcyBzdX Bwb3J0ZWQg YnnCoGEgcG hhc2UgMiBz dHVkeSBpbi B3aGljaCBu aXBvY2FsaW 1hYiBkZW1v bnN0cmF0ZW QgcmVkdWN0 aW9uIGluIG x1cHVzIGRp c2Vhc2UgYW N0aXZpdHkg YW5kIHBvdG VudGlhbCBm b3Igc3Rlcm 9pZCBzcGFy aW5nIHN5c3 RlbWljIGx1 cHVzIGVyeX RoZW1hdG9z dXMgaXMgYS BkZWJpbGl0 YXRpbmcsIG Nocm9uaWMg YXV0b2FudG lib2R5LWRy aXZlbiBkaX NlYXNlIGFm ZmVjdGluZy BtdWx0aXBs ZSBvcmdhbn MsIHdpdGgg bGltaXRlZC B0cmVhdG1l bnQgb3B0aW 9ucyBhbmQg cmlzayBvZi BpcnJldmVy c2libGUgb3 JnYW4gZGFt YWdlIGpvaG 5zb24gJiBq b2huc29uIG lzIGFjdGl2 ZWx5IGVucm 9sbGluZyBw YXRpZW50cy BpbiBhIHBo YXNlIDMgc3 R1ZHkgb2Yg YWR1bHRzIH dpdGggYWN0 aXZlIHN5c3 RlbWljIGx1 cHVzIGVyeX RoZW1hdG9z dXMgc3ByaW 5nIGhvdXNl LCBwYS4sIG 1hcmNoIDMs IDIwMjYgL3 BybmV3c3dp cmUvIC0tIG pvaG5zb24g JiBqb2huc2 9uIChueXNl OiBqbmopIH RvZGF5IGFu bm91bmNlZC B0aGF0IG5p cG9jYWxpbW FiYSB3YXMg Z3JhbnRlZC B1LnMuIGZv b2QgYW5kIG RydWcgYWRt aW5pc3RyYX Rpb24gKGZk YSkgZmFzdC B0cmFjayBk ZXNpZ25hdG lvbiBhcyBh IHBvdGVudG lhbCB0cmVh dG1lbnQgZm 9yIGFkdWx0 cyB3aXRoIH N5c3RlbWlj IGx1cHVzIG VyeXRoZW1h dG9zdXMgKH NsZSksIGEg ZGViaWxpdG F0aW5nIGF1 dG9hbnRpYm 9keS1kcml2 ZW4gZGlzZW FzZSB0aGF0 IGltcGFjdH MgYXBwcm94 aW1hdGVseS AzIHRvIDUg bWlsbGlvbi BwZW9wbGUg d29ybGR3aW RlLjEgdGhl IHUucy4gZm Rh4oCZcyBm YXN0IHRyYW NrwqBkZXNp Z25hdGlvbs KgcHJvZ3Jh bcKgaXMgZG VzaWduZWQg dG/CoGV4cG VkaXRlwqB0 aGUgZGV2ZW xvcG1lbnQg YW5kIHJldm lldyB0aW1l bGluZXMgb2 bCoGRydWdz IHRoYXTCoG RlbW9uc3Ry YXRlwqB0aG UgcG90ZW50 aWFsIHRvIH RyZWF0IHNl cmlvdXMgY2 9uZGl0aW9u cywgYWltaW 5nIHRvIGRl bGl2ZXLCoH RoZXJhcGV1 dGljcyB0by BwYXRpZW50 cyBtb3JlIH F1aWNrbHnC oGluwqBhcm VhcywgbGlr ZSBzbGUswq B3aGVyZcKg dW5tZXQgbm VlZHPCoHJl bWFpbi4ywq Ag4oCZbmlw b2NhbGltYW LCoGVhcm5p bmcgaXRzIG ZpZnRoIGZk YSBmYXN0IH RyYWNrIGRl c2lnbmF0aW 9uLCBub3cg aW4gc3lzdG VtaWMgbHVw dXMgZXJ5dG hlbWF0b3N1 cywgcmVmbG VjdHMgdGhl IGltcG9ydG FuY2Ugb2Yg YWNjZWxlcm F0aW5nIHRo ZSBkZWxpdm VyeSBvZiBh biBpbW11bm 9zZWxlY3Rp dmXCoHRoZX JhcHkgdGhh dCBjb3VsZC BmaWxsIGFu IHVubWV0IG 5lZWQgaW4g dGhpcyBzZX Jpb3VzIGNv bmRpdGlvbi zigJkgc2Fp ZCBsZW9uYX JkIGwu
|
| 2026-03-02 16:30:00 |
Sm9obnNvbi AmIEpvaG5z b24gVG8gSG 9zdCBJbnZl c3RvciBDb2 5mZXJlbmNl IENhbGwgT2 4gRmlyc3Qt cXVhcnRlci BSZXN1bHRz
TmV3IGJydW 5zd2ljaywg bi5qLi0tKG J1c2luZXNz IHdpcmUpLS 1qb2huc29u ICYgam9obn NvbiAobnlz ZTogam5qKS B3aWxsIGhv c3QgYSBjb2 5mZXJlbmNl IGNhbGwgZm 9yIGludmVz dG9ycyBhdC A4OjMwIGEu bS4gKGVhc3 Rlcm4gdGlt ZSkgb24gdH Vlc2RheSwg YXByaWwgMT R0aCB0byBy ZXZpZXcgZm lyc3QtcXVh cnRlciByZX N1bHRzLiBq b2FxdWluIG R1YXRvLCBj aGFpcm1hbi BhbmQgY2hp ZWYgZXhlY3 V0aXZlIG9m ZmljZXIsIG pvc2VwaCBq LiB3b2xrLC BleGVjdXRp dmUgdmljZS BwcmVzaWRl bnQgYW5kIG NoaWVmIGZp bmFuY2lhbC BvZmZpY2Vy IGFuZCBkYX JyZW4gc25l bGxncm92ZS wgdmljZSBw cmVzaWRlbn QsIGludmVz dG9yIHJlbG F0aW9ucyB3 aWxsIGhvc3 QgdGhlIGNh bGwuIHRoZS BxdWVzdGlv biBhbmQgYW 5zd2VyIHBv cnRpb24gb2 YgdGhlIGNh bGwgd2lsbC BhbHNvIGlu Y2x1ZGUgYW RkaXRpb25h bCBtZW1iZX JzIG9mIGpv aG5zb24gJi Bqb2gu
|
| 2026-02-26 14:30:00 |
RWFybHkgU3 R1ZHkgUmVz dWx0cyBGcm 9tIEpvaG5z b24gJiBKb2 huc29uIFNo b3cgUHJvbW lzaW5nIEFu dGl0dW1vci BBY3Rpdml0 eSBXaXRoIE NvbWJpbmF0 aW9uIE9mIF Bhc3JpdGFt aWcgQW5kIE RvY2V0YXhl bCBJbiBBZH ZhbmNlZCBQ cm9zdGF0ZS BDYW5jZXI=
Q29tYmluYX Rpb24gZGVt b25zdHJhdG VzIGRlZXAg cHNhIHJlc3 BvbnNlcyBh bmQgZmF2b3 JhYmxlIHNh ZmV0eSBwcm 9maWxlIHdp dGggcGxhbn MgdG8gYWR2 YW5jZSBpbn RvIHBoYXNl IDMgZGF0YS BoaWdobGln aHQgdGhlIH BvdGVudGlh bCBvZiB0aG lzIGZpcnN0 LWluLWNsYX NzIG5leHQt Z2VuZXJhdG lvbiB0LWNl bGwgZW5nYW dlciB0byBl eHBhbmQgdG hlIHJvbGUg b2YgaW1tdW 5vdGhlcmFw eSBpbiBwcm 9zdGF0ZSBj YW5jZXIgcm FyaXRhbiwg bi5qLiwgZm ViLiAyNiwg MjAyNiAvcH JuZXdzd2ly ZS8gLS0gam 9obnNvbiAm IGpvaG5zb2 4gKG55c2U6 am5qKSB0b2 RheSBhbm5v dW5jZWQgcH JlbGltaW5h cnkgcmVzdW x0cyBmcm9t IGEgcGhhc2 UgMWIgc3R1 ZHkgZXZhbH VhdGluZyBw YXNyaXRhbW lnIChqbmot NzgyNzgzND MpLCBhIGZp cnN0LWluLW NsYXNzIGJp c3BlY2lmaW MgdC1jZWxs IGVuZ2FnaW 5nIGFudGli b2R5LCBpbi Bjb21iaW5h dGlvbiB3aX RoIGRvY2V0 YXhlbCBpbi BwYXRpZW50 cyB3aXRoIG 1ldGFzdGF0 aWMgY2FzdH JhdGlvbi1y ZXNpc3Rhbn QgcHJvc3Rh dGUgY2FuY2 VyLg==
|
| 2026-02-24 16:03:00 |
Sm9obnNvbi AmIEpvaG5z b24gU2Vla3 MgRmRhIEFw cHJvdmFsIE 9mIEltYWF2 ecKuIChuaX BvY2FsaW1h Yi1hYWh1KS BBcyBUaGUg Rmlyc3QtZX ZlciBGZGEt YXBwcm92ZW QgVHJlYXRt ZW50IEZvci BXYXJtIEF1 dG9pbW11bm UgSGVtb2x5 dGljIEFuZW 1pYSAod2Fp aGEp
RGF0YSBmcm 9tIHRoZSBw aXZvdGFsIG VuZXJneSB0 cmlhbCBzaG 93ZWQgaW1h YXZ5wq4gcH JvZHVjZWQg YSByYXBpZC BhbmQgZHVy YWJsZSBoZW 1vZ2xvYmlu IHJlc3Bvbn NlYSBpbiB3 YWloYSBjdX JyZW50bHkg bm8gZmRhLW FwcHJvdmVk IHRoZXJhcG llcyBhcmUg YXZhaWxhYm xlIGZvciB3 YWloYSwgYS ByYXJlLCBo ZXRlcm9nZW 5lb3VzLCBs aWZlLXRocm VhdGVuaW5n IGRpc2Vhc2 UgaW4gd2hp Y2ggcGF0aG 9nZW5pYyBp bW11bm9nbG 9idWxpbiAo aWdnKSBhdX RvYW50aWJv ZGllcyBhdH RhY2ggdG8g YW5kIGRlc3 Ryb3kgcmVk IGJsb29kIG NlbGxzLCBs ZWFkaW5nIH RvIGRlYmls aXRhdGluZy BhbmVtaWEg c3ByaW5nIG hvdXNlLCBw YS4sIGZlYi 4gMjQsIDIw MjYgL3Bybm V3c3dpcmUv IC0tIGpvaG 5zb24gJiBq b2huc29uIC hueXNlOiBq bmopIHRvZG F5IGFubm91 bmNlZCB0aG Ugc3VibWlz c2lvbiBvZi BhIHN1cHBs ZW1lbnRhbC BiaW9sb2dp Y3MgbGljZW 5zZSBhcHBs aWNhdGlvbi Aoc2JsYSkg dG8gdGhlIH Uucy4gZm9v ZCBhbmQgZH J1ZyBhZG1p bmlzdHJhdG lvbiAoZmRh KSwgc2Vla2 luZyBhcHBy b3ZhbCBvZi BpbWFhdnnC riAobmlwb2 NhbGltYWIt YWFodSkgYX MgdGhlIGZp cnN0LWV2ZX IgdHJlYXRt ZW50IGZvci BwYXRpZW50 cyB3aXRoIH dhcm0gYXV0 b2ltbXVuZS BoZW1vbHl0 aWMgYW5lbW lhICh3YWlo YSkuYiB0aG lzIHJhcmUg YW5kIHNlcm lvdXMgYXV0 b2FudGlib2 R5IGRpc2Vh c2UgYWZmZW N0cyBhcHBy b3hpbWF0ZW x5IDEgaW4g OCwwMDAgaW 4gdGhlIHVu aXRlZCBzdG F0ZXMgYW5k IGN1cnJlbn RseSBoYXMg bm8gYXBwcm 92ZWQgdHJl YXRtZW50cy BkZXNwaXRl IHN1YnN0YW 50aWFsIHVu bWV0IG5lZW QuMSB0aGUg Y29uZGl0aW 9uIGlzIGFz c29jaWF0ZW Qgd2l0aCBz aWduaWZpY2 FudCBtb3Ji aWRpdHkgYW 5kIG1vcnRh bGl0eSwgd2 l0aCB0aG9z ZSBsaXZpbm cgd2l0aCB0 aGUgZGlzZW FzZSBmb3Vu ZCB0byBleH BlcmllbmNl IGEgMjAtMz AlIGhpZ2hl ciByaXNrIG 9mIGRlYXRo LjIg4oCZcG VvcGxlIGxp dmluZyB3aX RoIHdhcm0g YXV0b2ltbX VuZSBoZW1v bHl0aWMgYW 5lbWlhIGZh Y2UgYSBzZX Jpb3VzLCBs aWZlLXRocm VhdGVuaW5n IGRpc2Vhc2 Ugd2l0aCBu byBhcHByb3 ZlZCB0cmVh dG1lbnQgb3 B0aW9ucyBh bmQgYSBoaW doIHJpc2sg b2YgY29tcG xpY2F0aW9u cywgaW5jbH VkaW5nIHBy b2ZvdW5kIG Nocm9uaWMg ZmF0aWd1ZS wgdHJhbnNm dXNpb24gZG VwZW5kZW5j ZSwgYW5kIG 9yZ2FuIGZh aWx1cmUs4o CZIHNhaWQg ZGF2aWQgbS BsZWUsIG0u ZC4=
|
| 2026-02-23 10:28:00 |
QmF5ZXIgQW xsZWdlcyBK JmrigJlzIE NsYWltcyBS ZWdhcmRpbm cgTnViZXFh wq4gQXJlIE RlZXBseSBG bGF3ZWQgQW 5kIEludGVu dGlvbmFsbH kgQWltZWQg QXQgQm9vc3 RpbmcgU2Fs ZXMgT2YgSi Zq4oCZcyBF cmxlYWRh
V2hpcHBhbn ksIG4uai4t LShidXNpbm VzcyB3aXJl KS0tYmF5ZX IgYW5ub3Vu Y2VkIHRvZG F5IHRoYXQg aXQgaGFzIG ZpbGVkIHN1 aXQgYWdhaW 5zdCBqb2hu c29uICYgam 9obnNvbiAo aiZqKSBhbm QgamFuc3Nl biBiaW90ZW NoLCBpbmMu IGluIHRoZS B1bml0ZWQg c3RhdGVzIG Rpc3RyaWN0 IGNvdXJ0IG ZvciB0aGUg c291dGhlcm 4gZGlzdHJp Y3Qgb2Ygbm V3IHlvcmsu IHRoZSBzdW l0IGZvbGxv d3MgaiZq4o CZcyByZWZ1 c2FsIHRvIG NlYXNlIGFu ZCBkZXNpc3 QgaXRzIHBy b21vdGlvbi BvZiBhIHNj aWVudGlmaW NhbGx5IGZs YXdlZCByZW FsLXdvcmxk IGV2aWRlbm NlIGFuYWx5 c2lzIHRoYX QgbWlzaW5m b3JtcyBoZW FsdGhjYXJl IHByb3ZpZG VycyBhbmQg cGF0aWVudH MgaW4gYW4g ZWZmb3J0IH RvIGluY3Jl YXNlIGl0cy BtYXJrZXQg c2hhcmUgaW 4gYSBjb25j ZW50cmF0ZW QgYW5kIGlu Y3JlYXNpbm dseSBjb21w ZXRpdGl2ZS Bwcm9zdGF0 ZSBjYW5jZX IgdHJlYXRt ZW50IG1hcm tldC4=
|
